We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Health Canada has recalled a single lot of Eli Lilly Glucagon, as it may be contaminated. The lot number is D239382A, expiry May 10, 2022. Please check your glucagon kits and return it to the pharmacy if you have a vial with this lot number. All other lot numbers are fine.
For more information, click here: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/76507a-eng.php.
On May 5, 2025, Sanofi announced Health Canada approval of Tzield, the first disease-modifying therapy for type 1 diabetes (T1D). This is a huge win for the T1D community in that it is the first medicine to be approved in Canada that addresses the autoimmunity behind T1D – not just the symptoms that is causes. […]
Breakthrough T1D Board Member Matt Varey is cycling across Canada in support of type 1 diabetes research. Canada-wide May 1, 2025 – Beginning May 3, 2025, Matt Varey, retired banking executive, Vice Chair of Breakthrough T1D’s International Board, Board Member of Breakthrough T1D Canada and dedicated volunteer for the organization for over 20 years, will […]
March 19, 2025 – Saskatchewan – The Government of Saskatchewan made significant progress yesterday for people living with diabetes in Budget 2025 by announcing the expansion of public coverage for glucose monitoring systems and diabetes supplies for both seniors and young adults ages 25 and under. Previously, the province’s coverage only included children and youth under 18 who meet specific medical criteria.Both […]
Notifications
